(Q31418305)

English

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1 reference

based on heuristic

inferred from title

2

object named as

I J Dunkel

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

author name string

V Papadakis

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

L D Cramer

3

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

E Kramer

4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

E Papadopoulos

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

S Goldman

6

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

R J Packer

7

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

M Willoughby

8

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

D Baker

9

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

J Garvin

10

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

S Strandjord

11

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

P Coccia

12

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

A M Kaplan

13

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

M Klemperer

14

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

J L Finlay

15

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

153-160

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Surveillance scanning of children with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Do anticancer agents reach the tumor target in the human brain?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Etoposide (VP-16-213) in malignant brain tumors: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

"Outcome of post-radiation secondary glioblastoma in children".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

21 January 2018

Progress in the management of childhood brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702475

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702475

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Dimensions Publication ID

0 references

release_thj6m6maifdtrdurcbeiesxcnq

1 reference

https://api.fatcat.wiki/v0/release/thj6m6maifdtrdurcbeiesxcnq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31418305&oldid=2175448541"